BillionToOne, Inc. Class A Common StockBLLN
▲ ポジティブ資本関連度
BillionToOne's 49.5% YTD return, Zacks Rank 2 (Buy), and 122% upward earnings revision indicate strong financial performance and positive analyst sentiment.
資産への影響 2
Biotech & Genomic Medicine
BillionToOne, Inc. Class A Common StockHealth Care
Concentra Group Holdings Parent, Inc.CON
▲ ポジティブ資本関連度
Concentra Group's 56.4% YTD return, Zacks Rank 2, and 3.9% earnings estimate increase show positive financial momentum.